LyP-1-Modified Oncolytic Adenoviruses Targeting Transforming Growth Factor β Inhibit Tumor Growth and Metastases and Augment Immune Checkpoint Inhibitor Therapy in Breast Cancer Mouse Models.

Saved in:
Bibliographic Details
Title: LyP-1-Modified Oncolytic Adenoviruses Targeting Transforming Growth Factor β Inhibit Tumor Growth and Metastases and Augment Immune Checkpoint Inhibitor Therapy in Breast Cancer Mouse Models.
Authors: Xu, Weidong1 (AUTHOR), Yang, Yuefeng1,2 (AUTHOR), Hu, Zebin1,3 (AUTHOR), Head, Maria4 (AUTHOR), Mangold, Kathy A.4 (AUTHOR), Sullivan, Megan4 (AUTHOR), Wang, Edward5 (AUTHOR), Saha, Poornima6 (AUTHOR), Gulukota, Kamalakar7 (AUTHOR), Helseth, Donald L.7 (AUTHOR), Guise, Theresa8 (AUTHOR), Prabhkar, Bellur S.9 (AUTHOR), Kaul, Karen4 (AUTHOR), Schreiber, Hans10 (AUTHOR), Seth, Prem1 (AUTHOR) pseth@northshore.org
Source: Human Gene Therapy. Aug2020, Vol. 31 Issue 15-16, p863-880. 18p.
Database: Academic Search Ultimate
Description
ISSN:10430342
DOI:10.1089/hum.2020.078